Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for chronic back pain: electric pulses vs. steroid shots

NCT ID NCT07709689

Symptom relief Sponsor: National Cancer Institute, Egypt Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether pulsed radiofrequency (PRF) — a procedure that uses electrical pulses to calm nerves — can relieve sacroiliac joint pain better than standard steroid injections. Adults aged 18 to 65 with chronic pain lasting at least 6 months and a pain score above 5 out of 10 are eligible. Participants will receive either a steroid injection or PRF, and pain levels will be measured after one month.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pulsed radiofrequency (PRF) or conventional steroid injection
What this could lead to
If PRF proves more effective, it could offer longer-lasting pain relief for people with sacroiliac joint pain, reducing the need for repeat injections.
What could go wrong
This is a small, early-stage study with only 80 participants, so results may not apply to everyone. PRF is still experimental for this condition, and its benefits over standard care are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria * Sacroiliac Joint (SIJ) Pain * Diagnostic Block Response: Demonstrated a pain reduction of at least 50% following a diagnostic intra- articular SIJ block. * Failure of Medical Management * Chronic Pain Duration: Presence of chronic pain for a minimum duration of 6 months. * Pain Intensity: A pain intensity score greater than 5 on a 10-point Numeric Rating Scale (NRS), where 0 represents no pain and 10 represents the worst imaginable pain. * Age: Aged between 18 and 65 years. * Body Mass Index (BMI): A BMI within the range of 20 kg/m² to 35 kg/m². Exclusion Criteria: * Patient refusal. * Local infection at the puncture site. * Coagulopathies with platelets count below 50,000 or an INR\>1.6. * Unstable cardiovascular disease and Poor general condition and severe respiratory distress. * History of psychiatric and cognitive disorders or opioid addiction. * Patients are allergic to medication used. * Previous surgery to the affected site. * Rheumatological disease such as rheumatoid arthtritis or ankylsoing spondyolitis.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthritis, sacroiliac Chronic Pain chronic pain syndrome Sacroiliitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain Sacroiliitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.